HopeStage
Back to all studies
WithdrawnNCT01587066

Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Depression in bipolarity

Medication studyAges 20–65South Korea
The study in practice

Understand this study

Who could participate?

Listed age limits: 20 years to 65 years.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateAugust 2010
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Bo-Hyun Yoon
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
South Korea
Age range
From 20 Years to 65 Years
Official registry ID
NCT01587066
Official title
Show the full official title

Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression

Recruitment & locations

Withdrawn

Naju

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Bo-Hyun Yoon.

Does this study involve medication?

Yes. The study involves medication, including Quetiapine fumarate and Divalproex sodium.

Who can participate?

Listed age limits: 20 years to 65 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies